⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer

Official Title: An Open-label, Multicenter, Randomized Phase II Study to Compare the Effects of Paclitaxel/Carboplatin and Lonafarnib to Those of Paclitaxel/Carboplatin for First-line Treatment of Patients With Epithelial Ovarian Cancer FIGO Stages IIB-IV

Study ID: NCT00281515

Interventions

Lonafarnib

Study Description

Brief Summary: The purpose of this study is to compare the effects of Paclitaxel/Carboplatin and Lonafarnib to those of Paclitaxel/Carboplatin in primary treatment of patients with epithelial ovarian cancer.

Detailed Description: Today the standard therapy for patients with advanced ovarian carcinoma is paclitaxel and carboplatin. Lonafarnib is a farnesyl transferase inhibitor (FTI) that is active against a broad spectrum of tumor cell lines in vitro and tumor xenografts in nude mice. Lonafarnib has single-agent antitumor activity as well as enhanced activity in combination with taxanes in a number of tumor cell lines and in vivo models.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

CharitÊ - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik fßr Frauenheilkunde, Berlin, , Germany

Klinikum Bremen Mitte, Frauenklinik, Bremen, , Germany

Carl-Gustav-Carus der TU Dresden, Universitäts-Frauenklinik, Dresden, , Germany

Ev. Krankenhaus, Frauenklinik, DĂźsseldorf, , Germany

Klinik fĂźr Frauenheilkunde der Univ. Erlangen, Erlangen, , Germany

Universitätsfrauenklinik, Essen, , Germany

Klinikum der Johann Wolfgang Goethe Universität, Klinik fßr Frauenheilkunde u. Geburtshilfe, Frankfurt, , Germany

Universitätsklinikum Freiburg, Frauenklinik, Freiburg, , Germany

Kreiskrankenhaus, Frauenklinik, Gifhorn, , Germany

Klinik u. Poliklinik fßr Gynäkologie und Geburtshilfe, Greifswald, , Germany

Medizinische Hochschule, Hannover, , Germany

St. Vincentius-Krankenhäuser, Karlsruhe, , Germany

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik fßr Gynäkologie und Geburtshilfe, Kiel, , Germany

Klinik der Otto-von-Guericke Universität, Frauenklinik, Magdeburg, , Germany

Johannes-Gutenberg-Universität, Universitäts-Frauenklinik, Mainz, , Germany

Klinikum der Philipps-Universität Marburg, Klinik fßr Gynäkologie, Gynäkologische Endokrinologie, Marburg, , Germany

Klinikum Großhadern, Frauenklinik, München, , Germany

Klinikum rechts der Isar der TU MĂźnchen, MĂźnchen, , Germany

Elblandkliniken, Frauenklinik, Radebeul, , Germany

Klinikum SĂźdstadt, Rostock, , Germany

Universitäts-Frauenklinik, Tßbingen, , Germany

Universitätsfrauenklinik, Ulm, , Germany

Dr. Horst Schmidt Klinik, Gynäkologie u. Gynäkologische Onkologie, Wiesbaden, , Germany

Contact Details

Name: Werner Meier, Prof. Dr.

Affiliation: Ev. Krankenhaus, DĂźsseldorf, Germany

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: